Duquesne Family Office LLC / TGTX
Duquesne Family Office LLC’s Tg Therapeutics Inc Position
Does Duquesne Family Office LLC own Tg Therapeutics Inc (TGTX)? Not currently — the last reported position was 280.0K shares worth $4M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q1 2024
Shares
280.0K
% of Portfolio
+0.10%
Quarters Held
1
position exited
Position History TGTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2024 | 280.0K | $4M | +0.10% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of TGTX.